Evidence map›Paper›PMID 28520966›Full record

ReviewThe Journal of infectious diseases2017

Clonal Expansion of Human Immunodeficiency Virus-Infected Cells and Human Immunodeficiency Virus Persistence During Antiretroviral Therapy.

James I Mullins, Lisa M Frenkel

Abstract readReview
In one paragraph

Review in The Journal of infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. HIV-1 latency reversal agent boosting is not limited by opioid use.medRxiv : the preprint server for health sciences · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

James I MullinsDepartments of Microbiology, Medicine, Global Health and Laboratory Medicine, University of Washington, Seattle, WA, US.
Lisa M FrenkelDepartments of Pediatrics, Medicine, Global Health and Laboratory Medicine, University of Washington, Seattle, WA, US.

Funding

Mechanisms of Formation and Persistence of Active HIV ReservoirsR01AI111806 · NIAID · UNIVERSITY OF WASHINGTON · PI MULLINS, JAMES IVAN · 2014 to 2018
$4.3M
Role of proviral loci in HIV latencyR01AI125026 · NIAID · UNIVERSITY OF WASHINGTON · PI MULLINS, JAMES IVAN · 2016 to 2019
$3.4M
Mechanism/predictors of genital/rectal HIV shedding during ART w/plasma <50c/mLR01AI071212 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI FRENKEL, LISA M · 2006 to 2010
$2.4M
HIV-1 evolution in the female genital tract and trafficking to the bloodR01AI091550 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI FRENKEL, LISA M · 2011 to 2015
$1.9M
Ex Vivo Detection and Analysis of Non-inducible Latent HIVR33AI122361 · NIAID · UNIVERSITY OF WASHINGTON · PI MULLINS, JAMES IVAN · 2018 to 2020
$1.6M
HIV-1 evolution in the female genital tract and trafficking to the bloodR56AI091550 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI FRENKEL, LISA M · 2010 to 2010
$606k
Ex Vivo Detection and Analysis of Non-inducible Latent HIVR21AI122361 · NIAID · UNIVERSITY OF WASHINGTON · PI MULLINS, JAMES IVAN · 2016 to 2017
$478k
NIAID NIH HHS R01 AI071212NIAID NIH HHS R01 AI091550NIAID NIH HHS R01 AI111806NIAID NIH HHS R01 AI125026NIAID NIH HHS R21 AI122361NIAID NIH HHS R33 AI122361NIAID NIH HHS R56 AI091550
6 · The paper itself

Abstract

The latent HIV-1 reservoir in blood decays very slowly, even during prolonged suppression of viral replication by antiretroviral therapy (ART). Mechanisms for reservoir persistence include replenishment through low-level viral replication, longevity and homeostatic proliferation of memory T cells, and most recently appreciated, clonal expansion of HIV-infected cells. Clonally expanded cells make up a large and increasing fraction of the residual infected cell population on ART, and insertion of HIV proviruses into certain host cellular genes has been associated with this proliferation. That the vast majority of proviruses are defective clouds our assessment of the degree to which clonally expanded cells harbor infectious viruses, and thus the extent to which they contribute to reservoirs relevant to curing infection. This review summarizes past studies that have defined our current understanding and the gaps in our knowledge of the mechanisms by which proviral integration and clonal expansion sustain the HIV reservoir.

Indexed as

Antiretroviral Therapy, Highly ActiveVirus LatencyAnti-Retroviral AgentsCell ProliferationHIVHIV InfectionsHumansProvirusesAnti-Retroviral Agentscancer genesclonal proliferationHIV infected cell proliferationintegration sitesT-regulatory cells.

Identifiers

PMID28520966
PMCPMC6601388

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.